Olathe KS 前列腺癌临床试验
5项针对 前列腺癌的研究正在 Olathe及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- The University of Kansas Cancer Center - Olathe, Olathe
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- The University of Kansas Cancer Center - Olathe, Olathe
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- The University of Kansas Cancer Center - Olathe, Olathe
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- The University of Kansas Cancer Center - Olathe, Olathe
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Olathe Health Cancer Center, Olathe
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA60 项研究
- St. Louis, MO47 项研究
- San Francisco, CA45 项研究
- Chicago, IL45 项研究
- Seattle, WA44 项研究
- Philadelphia, PA44 项研究
- Nashville, TN43 项研究
- Baltimore, MD42 项研究
- Washington, DC38 项研究
Olathe的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。